27706190|t|Influence of Different Levels of Lipoic Acid Synthase Gene Expression on Diabetic Nephropathy
27706190|a|Oxidative stress is implicated in the pathogenesis of diabetic nephropathy (DN) but outcomes of many clinical trials are controversial. To define the role of antioxidants in kidney protection during the development of diabetic nephropathy, we have generated a novel genetic antioxidant mouse model with over- or under-expression of lipoic acid synthase gene (Lias). These models have been mated with Ins2Akita/+ mice, a type I diabetic mouse model. We compare the major pathologic changes and oxidative stress status in two new strains of the mice with controls. Our results show that Ins2Akita/+ mice with under-expressed Lias gene, exhibit higher oxidative stress and more severe DN features (albuminuria, glomerular basement membrane thickening and mesangial matrix expansion). In contrast, Ins2Akita/+ mice with highly - expressed Lias gene display lower oxidative stress and less DN pathologic changes. Our study demonstrates that strengthening endogenous antioxidant capacity could be an effective strategy for prevention and treatment of DN.
27706190	0	9	Influence	T077	C4054723
27706190	13	22	Different	T080	C1705242
27706190	23	29	Levels	T079	C1306673
27706190	33	53	Lipoic Acid Synthase	T028	C1424272
27706190	54	69	Gene Expression	T045	C0017262
27706190	73	93	Diabetic Nephropathy	T047	C0011881
27706190	94	110	Oxidative stress	T049	C0242606
27706190	132	144	pathogenesis	T046	C0699748
27706190	148	168	diabetic nephropathy	T047	C0011881
27706190	170	172	DN	T047	C0011881
27706190	178	186	outcomes	T169	C1274040
27706190	195	210	clinical trials	T062	C0008976
27706190	244	248	role	T077	C1705810
27706190	252	264	antioxidants	T121	C0003402
27706190	268	274	kidney	T023	C0022646
27706190	286	292	during	T079	C0347984
27706190	297	308	development	T169	C1527148
27706190	312	332	diabetic nephropathy	T047	C0011881
27706190	342	351	generated	T052	C3146294
27706190	354	359	novel	T080	C0205314
27706190	360	391	genetic antioxidant mouse model	T050	C2986594
27706190	397	422	over- or under-expression	T045	C0017262
27706190	426	451	lipoic acid synthase gene	T028	C1424272
27706190	453	457	Lias	T028	C1424272
27706190	466	472	models	T050	C2986594
27706190	483	488	mated	T040	C1260875
27706190	494	510	Ins2Akita/+ mice	T015	C0025929
27706190	514	529	type I diabetic	T047	C0836995
27706190	530	541	mouse model	T050	C2986594
27706190	546	553	compare	T052	C1707455
27706190	558	563	major	T080	C0205164
27706190	564	582	pathologic changes	T034	C4086730
27706190	587	603	oxidative stress	T049	C0242606
27706190	604	610	status	T080	C0449438
27706190	637	641	mice	T015	C0025929
27706190	661	668	results	T169	C1274040
27706190	679	695	Ins2Akita/+ mice	T015	C0025929
27706190	701	716	under-expressed	T045	C0017262
27706190	717	726	Lias gene	T028	C1424272
27706190	736	742	higher	T080	C0205250
27706190	743	759	oxidative stress	T049	C0242606
27706190	764	768	more	T081	C0205172
27706190	769	775	severe	T080	C0205082
27706190	776	778	DN	T047	C0011881
27706190	779	787	features	T080	C2348519
27706190	789	800	albuminuria	T033	C0001925
27706190	802	841	glomerular basement membrane thickening	T033	C0445347
27706190	846	872	mesangial matrix expansion	T033	C3553722
27706190	888	904	Ins2Akita/+ mice	T015	C0025929
27706190	910	916	highly	T080	C0205250
27706190	919	928	expressed	T045	C0017262
27706190	929	938	Lias gene	T028	C1424272
27706190	939	946	display	T169	C0870432
27706190	947	952	lower	T080	C0205251
27706190	953	969	oxidative stress	T049	C0242606
27706190	974	978	less	T080	C0547044
27706190	979	981	DN	T047	C0011881
27706190	982	1000	pathologic changes	T034	C4086730
27706190	1006	1011	study	T062	C2603343
27706190	1012	1024	demonstrates	T052	C3687625
27706190	1044	1054	endogenous	T169	C0205227
27706190	1055	1066	antioxidant	T121	C0003402
27706190	1067	1075	capacity	T081	C1516240
27706190	1088	1121	effective strategy for prevention	UnknownType	C0679723
27706190	1126	1135	treatment	T169	C1522326
27706190	1139	1141	DN	T047	C0011881